➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Mallinckrodt
Boehringer Ingelheim
McKesson
Dow

Last Updated: January 28, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Delamanid

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the drug development status for Delamanid?

Delamanid is an investigational drug.

There have been 18 clinical trials for Delamanid. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2003.

The most common disease conditions in clinical trials are Tuberculosis, Tuberculosis, Multidrug-Resistant, and Tuberculosis, Pulmonary. The leading clinical trial sponsors are Otsuka Pharmaceutical Development & Commercialization, Inc., National Institute of Allergy and Infectious Diseases (NIAID), and Partners in Health.

Recent Clinical Trials for Delamanid
TitleSponsorPhase
PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE)Ludwig-Maximilians - University of MunichPhase 2
PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE)Radboud UniversityPhase 2
PanACEA DElpazolid Dose-finding and COmbination DEvelopment (DECODE)University of California, San FranciscoPhase 2

See all Delamanid clinical trials

Clinical Trial Summary for Delamanid

Top disease conditions for Delamanid
Top clinical trial sponsors for Delamanid

See all Delamanid clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
Mallinckrodt
Boehringer Ingelheim
McKesson
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.